The drugs industry is an enormous multibillion businesses encompassing an immense number of companies involved in the design, production and marketing of drugs worldwide. According to the type of drugs the market can be dived into the following segments: diabetes, antifungal, antidepressant, antithrombotic, hepatitis drugs, analgesics and a far more.
Currently, the drugs market is undergoing a recovery phase in the wake of the recent decline provoked by the economic slump. The market growth is spurred by increasing demand for drugs across the globe, rising incidence of chronic as well as infectious diseases, population ageing, product innovations and constant technological advancements. North America and Europe are the most prominent regional markets. Bristol-Myers Squibb, Pharmacia, GlaxoSmithKline, Merck & Co, Novartis, Eli Lilly, Pfizer, Johnson & Johnson, Allergan, Schering-Plough, Bayer and Abbott Labs are amid global drugs arena giants.
A huge collection of the research reports covering the drugs market at different geographies can be found under this MarketPublishers’ catalogue. The researches provide comprehensive assessment of the market, characterize major market trends and disclose essential market indicators. The reports describe the competitive scenario and indicate top market players. In addition, future prospects for the drugs market are thoroughly studied in the research reports.
Publications found:
8,552
Sort by:
Antithrombotic Drugs: World Market 2013-2023
US$ 2,635.00
... What prospects for leading countries? Developments worldwide will influence the market, especially rising demand in emerging countries - e.g. Brazil and China. Our ... possibilities, helping you stay ahead. Nine ways Antithrombotic Drugs: World Market 2013-2023 helps To sum up, our investigation gives you ...
February 2013
119 pages
Research Report on China’s Anti-Alzheimer’s Disease (AD) Drug Market, 2013-2017
US$ 2,800.00
... the end of 2011, people aged 60 and above reached 185 million in China, accounting for 13.7% of the population, with an increase of 0.47 percentage point compared ... market development also accelerates. Although the overall market size of China's anti-AD drug market is relatively small, the growth rate is always ...
January 2013
40 pages
The U.S. Market for Rx to OTC Switches, 6th Edition
US$ 3,995.00
... product areas contribute to the growth and development of the OTC market; however, new product development and additional regulatory review and ... label manufacturers. Competition will likely continue to be moderate in the OTC market, especially with the patent expiration of key products nearing. Consolidation ...
January 2013
290 pages
China Insulin Industry Report, 2012-2015
US$ 1,800.00
... analog market in 2011. In April 2012, the insulin phase Ⅲ project of the company held the groundbreaking ceremony. Once the project is put ... . The report highlights the followings: Global insulin industry: development, supply & demand, product R&D, competition pattern, development trend, etc. China insulin ...
January 2013
70 pages
Parkinson's Disease: World Drug Market 2013-2023
US$ 2,400.00
... Pain treatment Nicotinic receptor targeting. Also, our work covers the disease modification field, including: Possible neuroprotectants (including Azilect) Biomarkers GDNF ... for those CNS treatments. Eight main ways Parkinson's Disease: World Drug Market 2013-2023 helps you In particular, then, our ...
January 2013
161 pages
2013 Drugs of Abuse Testing Market: US, Europe, Japan
US$ 6,000.00
... from Venture Planning Group contains 311 pages and 61 tables. 'Drugs of Abuse Testing Market: US, Europe, Japan' is a unique study designed to help current ... start resembling commodity markets, where product positioning and cost per test are more critical than underlying technology. This evolving marketplace ...
December 2012
311 pages
Research Report on China's Antidepressant Market, 2013-2017
US$ 2,800.00
... , with the increasing recognition rate of doctors for depression and people's changes in treatment concepts, it is expected that the future potential of China's antidepressant market is fairly great. It is predicted that in coming years, the annual growth rate of market size of China's antidepressants in ...
December 2012
50 pages
Research Report on China's Antifungal Drug Market, 2013-2017
US$ 2,800.00
... of fungi increasingly enhances, so it indicates a sharply rising trend for the clinical application of antifungal drugs. It is expected that in coming years, the annual growth rate of market size of China's antifungal drugs will be over 20%. As for manufacturers, there are many opportunities. ...
December 2012
50 pages
Research Report on China's Diabetes Drug Market, 2013-2017
US$ 2,800.00
... aged above 20 has reached over 9.7%, and the morbidity rate of pre-diabetes (impaired fasting glucose and impaired glucose tolerance) has reached ... the market positions of insulin preparations and Acarbose. The market size of China's diabetes drugs is expected to maintain an annual growth rate of over 18% from ...
December 2012
50 pages
Research Report on China's Antithrombotic Drug Market, 2013-2017
US$ 2,400.00
... , the morbidity and mortality rates of cardiac-cerebral thrombotic diseases in China are higher than that in some developed countries. In addition, patients ... aggregation drugs and thrombolytic drugs. The overall market size of China's antithrombotic drugs is small, but it rapidly grows in recent years. The ...
December 2012
40 pages
Drug Discovery Outsourcing: World Market 2013-2023
US$ 2,400.00
... prospects in leading regions and countries? Developments worldwide will influence the market, especially rising demand in emerging countries - China, India and others. ... shows you the commercial possibilities. Seven ways Drug Discovery Outsourcing: World Market 2013-2023 helps you In particular, then, our ...
November 2012
157 pages
Research Report on China's Hypolipidemic Drug Market, 2012-2013
US$ 2,400.00
... , the overall morbidity rate of dyslipidemia groups aged 18 and above is over 20% in China, and total patients are over 200 million nationwide. Blood ... , thus occupying a most advantageous position clinically. The overall performance of China's hypolipidemic drugs in the drug market is better than that of the ...
November 2012
55 pages
Generic Drugs: World Market 2013-2023
US$ 2,400.00
... 2012 onwards: US, European and Japanese regulations Authorised, branded and other generics, including modified products Patent expiries and business strategies, including ... . You see how revenues can increase. Nine ways Generic Drugs: World Market 2013-2023 benefits you To sum up, our report gives you ...
November 2012
149 pages
Macular Degeneration (AMD) and Diabetic Retinopathy (DR): World Drug Market 2013-2023
US$ 2,401.00
... you discover its potential Where are treatments for macular degeneration (AMD) and diabetic retinopathy (DR) heading? Visiongain's updated report gives you ... will reach $6.25bn in 2015, our report forecasts. Ageing populations, diabetes and improving healthcare will increase sales of retinal drugs. In our ...
November 2012
153 pages
Pharma Leader Series: Top 20 Ophthalmic Drug Manufacturers 2012-2022
US$ 2,401.00
... ? Our study also covers 20 other companies following after the world leaders. You discover activities of organisations including the following: BioDiem CoMentis ... will develop and prosper, our analysis shows. Nine ways Pharma Leader Series: Top 20 Ophthalmic Drug Manufacturers 2012-2022 benefits you To ...
October 2012
166 pages
Alzherimer's Drugs Market, 2012-2017
US$ 1,699.00
... five years, from 2012-2017, will see the launch of many new drugs. Scope of the Report The Alzheimer’s drug market (2011-2017) ... III clinical trials. Chapter 8 provides profiles of the key companies in this market. Each company profile includes information such as financial performance, geographical ...
October 2012
117 pages
Pharma Leader Series: Top 25 Biosimilar Drug Manufacturers 2012-2022
US$ 2,401.00
... - you see prospects to 2022 for Sandoz Will Sandoz remain the market leader? See information on its activities in 2012, looking ahead. You find discussion ... leading generics specialists - will develop and prosper. Eight ways Pharma Leader Series: Top 25 Biosimilar Drug Manufacturers 2012-2022 helps you To ...
October 2012
182 pages
Data report-Production Situation of Vitamin B2
US$ 1,490.00
... This report provides you concise information about the vitamin B2 industry in China, discovering not only the latest dynamics of production situation and producers ... , but also price, import and export, and the application fields of the vitamin B2 products. Besides, ...
September 2012
13 pages
World Multiple Myeloma Drug Treatment Market 2012-2022
US$ 2,635.00
... will arise for companies treating cancers. Nine ways World Multiple Myeloma Drug Treatment Market 2012-2022 helps you In particular, then, ... following knowledge on the topic: Forecasted revenue to 2022 for the overall world market - find the industry's prospects Potential revenues of 10 products to 2022 ...
September 2012
136 pages
The World Market for Transdermal Drug Delivery
US$ 2,500.00
... and the ability to quickly discontinue treatment by removal of the system. This report, World Markets for Transdermal Drug Delivery is a comprehensive look at the ... , revenues have been reported that include pharmaceutical sales for products utilizing that technology. This market is divided into two segments ...
September 2012
100 pages
Pharma Leader Series: Top 20 Biological Drug Manufacturers 2012-2022
US$ 2,635.00
... top sales places. Also, most of those products will continue revenue growth. Seven ways Pharma Leader Series: Top 20 Biological Drug Manufacturers 2012-2022 helps you In particular, our report gives you the following knowledge on producers of biologics: Profiles of 20 leading ...
September 2012
187 pages
Global Generic Drugs Industry 2012-2017: Trend, Profit, and Forecast Analysis, September 2012
US$ 1,980.00
... , a leading global management consulting and market research firm, has analyzed the global generic drugs industry and presents its findings in Global Generic Drugs Industry 2012-2017: Trend, Profit, and Forecast Analysis. The industry comprises firms primarily engaged in the development, manufacture, and marketing of generic drugs. The generic ...
September 2012
OTC Triptans in Germany
US$ 990.00
... for a considerable further increase of category value sales in Germany in 2011. Euromonitor International's OTC Triptans in Germany report offers a comprehensive guide to the size and shape ... data. Why buy this report? Get a detailed picture of the OTC Triptans market; Pinpoint growth sectors and identify factors driving change ...
July 2012
27 pages
Cempra: “GAIN from Drugs for Bad Bugs”
US$ 140.00
Drug resistance is a growing concern worldwide and Cempra (CEMP) is one of our lead recommendations ... offer an attractive investment opportunity in this therapy class. CEMP’s lead drug, 1. Solithromycin (CEM-101, PhIII, CABP; PhII cUTI) ... released on 2nd July, 2012 on CEMP titled “GAIN from Drugs for Bad Bugs”
July 2012
9 pages
China Genetic Engineering Drug Industry Report, 2011-2012
US$ 1,900.00
China gets a late start in developing genetic engineering drug industry, but has achieved leapfrog advance. At present, China has at least one hundred enterprises involved in genetic engineering drugs...
June 2012
80 pages
Needle-Free Drug Injection Systems and Safety Syringes: Market Research Report
US$ 4,600.00
This report analyzes the worldwide markets for Needle-Free Drug Injection Systems and Safety Syringes in US$ Million. The report provides ... , Inc., Cambridge Consultants Ltd., Antares Pharma, Inc., Bard Biopsy Systems, Baxter International, Inc., Baxter BioPharma Solutions, Bector, Dickinson, BD Medical, ...
June 2012
504 pages
Pharma Leader Series: Top 20 Antibacterial Drug Manufacturers 2012-2022
US$ 2,635.00
Report Details Antibacterial medicines - discover performance and commercial prospects of companies How are leading companies in the antibacterial drugs market performing? Visiongain's new report gives you data, analyses and revenue predictions for antibacterial manufacturers. See how top companies ...
June 2012
185 pages
Prioritizing Generic Drug development pipeline – The top Fifty Opportunities
US$ 5,000.00
... crucial aspects of growth strategy for a generic company or an Active Pharmaceutical Ingredient manufacturing ... recently approved or are in late stage development / Filed but with significantly success probability ... / therapeutic value compared to marketed drugs Anticipated competition in the therapy and ...
June 2012
100 pages
OTC Drug Market in India 2012
US$ 950.00
... days after order is placed. Over-the-counter drug market in India ranks eleventh in the global OTC market and is expected to reach the ninth position ... tendency for self treatment, the Indian market is characterized by a huge demand for OTC drugs. It is a highly fragmented market with a large number of foreign ...
June 2012
85 pages
Production Situation of Vitamin E in China
US$ 1,620.00
In volume of transaction, Vitamin E is one of the world's top three vitamins with annual global market volume of nearly USD1 billion, thanks to the wide range of applications in feed, medicine and foo...
June 2012
20 pages
Effective Sales and Marketing Strategies for Orphan Drugs
US$ 695.00
The real potential for orphan drug pharma marketing With drug pipelines moving from essential products to niche therapies, large pharma companies are increasingly attracted to the prospective high de...
May 2012
117 pages
Insulin Market Forecast to 2015
US$ 400.00
In the global biopharmaceutical industry, protein-based therapies are effectively being used to treat metabolic disorders, and autoimmune diseases. According to our new research report, the global mar...
May 2012
42 pages
Calming and Sleeping in Thailand
US$ 990.00
Claiming and sleeping products was previously present in Thailand in the form of some herbal calming and sleeping products, such as Baracol, Calmaco, Passiflora and Cassia ... . Consequently, these herbal calming and sleeping products was banned for sale over the counter... Euromonitor International's Calming and Sleeping in Thailand report offers a comprehensive ...
May 2012
23 pages
Emergency Contraception in Slovakia
US$ 990.00
... as a regular method of contraception. An overall decrease in value growth was evident each year as a result of changing lifestyles of females. In general emergency contraception is considered a last resort for many women as such medication has the... Euromonitor International's Emergency Contraception in Slovakia report offers a comprehensive ...
May 2012
20 pages
World Market for Over The Counter (OTC) Drugs, The
US$ 3,995.00
... more revenue and international exposure have found an opportunity in the development of over-the-counter (OTC) drugs. OTC drugs are sold to consumers ... marketing directors, division managers, and product representatives. All market data pertains to the world market at the manufacturers’ level. The base year ...
May 2012
190 pages
Kidney Cancer Drugs: Market Research Report
US$ 4,500.00
... report analyzes the worldwide markets for Kidney Cancer Drugs in US$ Million. This report on 'Kidney Cancer Drugs' provides market analytics specifically for ... Ltd., GlaxoSmithKline Plc, Merck-Serono, Novartis AG, Pfizer, Inc., and WILEX AG. Market data and analytics are derived from primary and secondary ...
April 2012
297 pages
